Reductions in Occipital Cortex GABA Levels in Panic Disorder Detected With 1H-Magnetic Resonance Spectroscopy
Author(s) -
Andrew W. Goddard,
Graeme F. Mason,
Ahmad Almai,
Douglas L. Rothman,
Kevin L. Behar,
Ognen A. C. Petroff,
Dennis S. Charney,
John H. Krystal
Publication year - 2001
Publication title -
archives of general psychiatry
Language(s) - English
Resource type - Journals
eISSN - 1538-3636
pISSN - 0003-990X
DOI - 10.1001/archpsyc.58.6.556
Subject(s) - panic disorder , agoraphobia , psychology , panic , anxiety disorder , anxiolytic , medicine , gamma aminobutyric acid , pathophysiology , anxiety , psychiatry , neuroscience , endocrinology , receptor
There is preclinical evidence and indirect clinical evidence implicating gamma-aminobutyric acid (GABA) in the pathophysiology and treatment of human panic disorder. Specifically, deficits in GABA neuronal function have been associated with anxiogenesis, whereas enhancement of GABA function tends to be anxiolytic. Although reported peripheral GABA levels (eg, in cerebrospinal fluid and plasma) have been within reference limits in panic disorder, thus far there has been no direct assessment of brain GABA levels in this disorder. The purpose of the present work was to determine whether cortical GABA levels are abnormally low in patients with panic disorder.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom